Physician profile
Eric C Cox
NPI 1578560231
$7,390.26
in general payments reported to CMS, 2019-2025
48 companies · $1,036 in 2025
The $1,036 reported for 2025 was more than what 86% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $284 · 2020: $217 · 2021: $852 · 2022: $1,607 · 2023: $1,791 · 2024: $1,603 · 2025: $1,036.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,430.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,429.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $776.10 | 2020-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Novo Nordisk INC | $741.98 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Abbvie INC. | $610.83 | 2021-2025 | Ubrelvy, Vraylar, Qulipta |
| Abbott Laboratories | $469.42 | 2021-2025 | Freestyle Libre 3, Proclaim |
| Pfizer INC. | $404.42 | 2019-2025 | |
| Lilly USA, LLC | $374.40 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Astrazeneca Pharmaceuticals LP | $344.90 | 2020-2025 | Farxiga, Airsupra, Breztri |
| Axsome Therapeutics, INC. | $339.11 | 2023-2025 | Auvelity |
| Janssen Pharmaceuticals, INC | $334.87 | 2021-2024 | Xarelto, Spravato |
| Otsuka America Pharmaceutical, INC. | $288.95 | 2022-2025 | Rexulti |
| Bayer Healthcare Pharmaceuticals INC. | $280.28 | 2022-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $211.66 | 2020-2025 | Trintellix |
| Phathom Pharmaceuticals, INC. | $199.56 | 2024-2025 | Voquezna |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $192.32 | 2021-2024 | Xifaxan, Trulance |
| Kowa Pharmaceuticals America, INC. | $181.45 | 2019-2024 | Livalo, Seglentis, Zoryve |
Show all 48 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $172.36 | 2019-2025 | Repatha, Otezla, Otezla |
| Boehringer Ingelheim Pharmaceuticals, INC. | $157.96 | 2022-2025 | Jardiance |
| Biohaven Pharmaceutical Holding Company LTD. | $137.66 | 2022 | |
| Sunovion Pharmaceuticals INC. | $105.13 | 2019 | |
| Exact Sciences Corporation | $83.19 | 2023-2024 | Cologuard Collection Kit |
| Lundbeck LLC | $80.76 | 2022-2024 | Rexulti |
| Sanofi-Aventis U.S. LLC | $74.95 | 2019-2022 | |
| Dexcom, INC. | $67.20 | 2023-2025 | Dexcom G6 Transmitter |
| Biogen, INC. | $66.46 | 2021-2022 | |
| Nestle Healthcare Nutrition INC. | $64.19 | 2022-2023 | |
| Antares Pharma, INC. | $61.51 | 2021-2023 | Xyosted, Tlando, Nocdurna |
| Merck Sharp & Dohme LLC | $54.07 | 2020-2022 | |
| Novartis Pharmaceuticals Corporation | $48.23 | 2022-2023 | |
| Boston Scientific Corporation | $47.51 | 2023 | Watchman Flx |
| Idorsia Pharmaceuticals US INC | $46.59 | 2023-2024 | Quviviq |
| Eisai INC. | $38.16 | 2025 | |
| Arbor Pharmaceuticals, INC. | $33.67 | 2020-2021 | |
| International Rehabilitative Sciences, INC | $32.11 | 2025 | Rs-4i Plus With Intersperse |
| Bolton Medical INC | $30.15 | 2024 | Treo Abdominal Stent-Graft System |
| Ars Pharmaceuticals Operations, INC. | $26.96 | 2025 | Neffy |
| Beta Bionics, INC. | $22.32 | 2024 | Ilet Bionic Pancreas |
| Amarin Pharma, INC. | $21.57 | 2019 | |
| Allergan, INC. | $18.70 | 2019 | |
| Biohaven Pharmaceuticals, INC. | $18.66 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $16.00 | 2024 | Austedo Xr |
| Horizon Therapeutics Plc | $15.79 | 2022 | |
| Xeris Pharmaceuticals, INC. | $15.78 | 2023 | Gvoke Hypopen |
| E.R. Squibb & Sons, L.L.C. | $14.84 | 2022 | |
| Acella Pharmaceuticals, LLC | $14.77 | 2025 | NP Thyroid 60 |
| Philips North America LLC | $14.47 | 2023 | |
| Halozyme INC | $14.08 | 2023 | |
| Optinose US, INC. | $13.34 | 2021 | |
| Aytu Biopharma, INC. | $10.87 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Cox listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.